Delivery Order SPE2DB22D2218-SPE2DB25FR3FW
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90-count) with a ceiling value of $17,047.43. This competitively awarded, firm fixed-price delivery order represents a non-set-aside procurement and is due for completion by August 13, 2025. The award was executed from AmerisourceBergen's location in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $97,006.28 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-25 mg tablets (90-count) under a firm fixed price contract. The award, issued on July 23, 2025, with completion by July 24, 2025, represents a competitive procurement with no set-aside designation. Performance will be executed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $20,575.76 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) under a firm fixed price arrangement. The award was made on August 1, 2025, with an ultimate completion date of August 4, 2025, and is classified as a non-set-aside competitive procurement. Performance will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Diovan HCT 160-12.5 mg tablets (90 count) with a contract value of $2,386.06. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 20, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting AmerisourceBergen's capability...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of Diovan HCT 160-25 mg tablets (90 count) with a ceiling value of $1,038.57. This is a firm fixed-price delivery order with no set-aside designation, issued under a competitive procurement process. The order is scheduled for completion by August 11, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. This delivery order represents a task...
- The Defense Logistics Agency awarded a delivery order valued at $6,096.46 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count units). The contract represents a firm fixed price, non-set-aside procurement with an ultimate completion date of July 28, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,090.39 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Diovan HCT 80-12.5 mg tablets (90-count bottles). This competitive award, issued without set-aside designation, utilizes firm fixed pricing and is scheduled for completion by August 19, 2025. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $5,570.45 to AmerisourceBergen Drug Corp for the supply of Diovan HCT 320-25 mg tablets (90-count units) under a firm fixed price arrangement. The contract was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025, and does not utilize a set-aside designation. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $1,918.37 firm fixed-price delivery order to AmerisourceBergen Drug Corp for DIOVAN HCT 160-25 mg tablets (90-count supply), with completion targeted for August 1, 2025. This non-set-aside competitive award represents a direct fulfillment of pharmaceutical supply requirements under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Diovan HCT 320-12.5 mg tablets (90-count) with a firm fixed price ceiling value of $1,746.64. This non-set-aside, competitively awarded contract is scheduled for ultimate completion on July 22, 2025, with performance taking place at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's critical...
- SPE2DB22D2218Indefinite Delivery Contract
- SPE2DB22D2218-SPE2DB25FR3FWDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Diovan HCT 160-12.5 mg tablets (90-count) valued at $20,722.73 under a firm fixed-price contract with an ultimate completion date of August 26, 2025. The award, issued on August 25, 2025, was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this contract at its corporate office location in the same area. This delivery order represents a single transaction within AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle enables the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs and other federal healthcare systems worldwide. As a critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains a substantial portfolio of pharmaceutical product deliveries across multiple therapeutic domains, demonstrating consistent capability to meet competitive federal procurement requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $20.7k | 8/25/25 |